glp 1 donald trump President Trump, Dr. Mehmet Oz and a representative from the drug company, Eli Lilly spoke to press about the side-effects of GLP-1 drugs after announcing a massive cut in price of the drugs. U.S. President Donald Trump has

The market is moving from awareness to conversion

USD 929.3 million in absolute opportunity is expected between 2026 and 2036, led by Mobile adherence apps and Dose reminders and tracking alongside Direct-to-consumer deployment and Health plans

Here is how Found Health's cost structure breaks down based on the company's publicly available information and third-party reporting

"I don't think the companies have leveled with the American public on how these drugs work," says Kessler

An Overview of Ozempic Ozempic is a medication containing the active ingredient semaglutide and is approved by the FDA for use in managing type 2 diabetes